Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 2
1957 1
1962 1
1972 2
1973 1
1974 1
1976 2
1979 1
1981 1
1982 1
1983 3
1986 1
1987 2
1988 1
1990 2
1991 8
1992 3
1993 3
1994 6
1995 8
1996 7
1997 3
1998 3
1999 2
2000 4
2001 5
2002 2
2003 8
2004 5
2005 6
2006 10
2007 12
2008 19
2009 20
2010 27
2011 25
2012 25
2013 28
2014 43
2015 27
2016 27
2017 26
2018 30
2019 26
2020 39
2021 42
2022 39
2023 22

Text availability

Article attribute

Article type

Publication date

Search Results

521 results

Results by year

Filters applied: . Clear all
Page 1
Effects of microbiota-directed foods in gnotobiotic animals and undernourished children.
Gehrig JL, Venkatesh S, Chang HW, Hibberd MC, Kung VL, Cheng J, Chen RY, Subramanian S, Cowardin CA, Meier MF, O'Donnell D, Talcott M, Spears LD, Semenkovich CF, Henrissat B, Giannone RJ, Hettich RL, Ilkayeva O, Muehlbauer M, Newgard CB, Sawyer C, Head RD, Rodionov DA, Arzamasov AA, Leyn SA, Osterman AL, Hossain MI, Islam M, Choudhury N, Sarker SA, Huq S, Mahmud I, Mostafa I, Mahfuz M, Barratt MJ, Ahmed T, Gordon JI. Gehrig JL, et al. Among authors: choudhury n. Science. 2019 Jul 12;365(6449):eaau4732. doi: 10.1126/science.aau4732. Science. 2019. PMID: 31296738 Free PMC article. Clinical Trial.
Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers.
Choudhury NJ, Marra A, Sui JSY, Flynn J, Yang SR, Falcon CJ, Selenica P, Schoenfeld AJ, Rekhtman N, Gomez D, Berger MF, Ladanyi M, Arcila M, Rudin CM, Riely GJ, Kris MG, Heller G, Reis-Filho JS, Yu HA. Choudhury NJ, et al. J Thorac Oncol. 2023 Apr;18(4):463-475. doi: 10.1016/j.jtho.2022.11.022. Epub 2022 Dec 6. J Thorac Oncol. 2023. PMID: 36494075
Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in ROS1 Fusion-Positive Lung Cancer.
Lin JJ, Choudhury NJ, Yoda S, Zhu VW, Johnson TW, Sakhtemani R, Dagogo-Jack I, Digumarthy SR, Lee C, Do A, Peterson J, Prutisto-Chang K, Malik W, Hubbeling HG, Langenbucher A, Schoenfeld AJ, Falcon CJ, Temel JS, Sequist LV, Yeap BY, Lennerz JK, Shaw AT, Lawrence MS, Ou SI, Hata AN, Drilon A, Gainor JF. Lin JJ, et al. Among authors: choudhury nj. Clin Cancer Res. 2021 May 15;27(10):2899-2909. doi: 10.1158/1078-0432.CCR-21-0032. Epub 2021 Mar 8. Clin Cancer Res. 2021. PMID: 33685866 Free PMC article.
Multimode Mamyshev oscillator.
Haig H, Sidorenko P, Dhar A, Choudhury N, Sen R, Christodoulides D, Wise F. Haig H, et al. Among authors: choudhury n. Opt Lett. 2022 Jan 1;47(1):46-49. doi: 10.1364/OL.447208. Opt Lett. 2022. PMID: 34951879
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas.
Selenica P, Marra A, Choudhury NJ, Gazzo A, Falcon CJ, Patel J, Pei X, Zhu Y, Ng CKY, Curry M, Heller G, Zhang YK, Berger MF, Ladanyi M, Rudin CM, Chandarlapaty S, Lovly CM, Reis-Filho JS, Yu HA. Selenica P, et al. Among authors: choudhury nj. Ann Oncol. 2022 Dec;33(12):1284-1295. doi: 10.1016/j.annonc.2022.09.151. Epub 2022 Sep 9. Ann Oncol. 2022. PMID: 36089134 Free article.
Choudhury N. Choudhury N. HCA Healthc J Med. 2022 Jun 28;3(3):217-218. doi: 10.36518/2689-0216.1357. eCollection 2022. HCA Healthc J Med. 2022. PMID: 37424614 Free PMC article.
Mixed-Matrix Membrane Fabrication for Water Treatment.
Siddique T, Dutta NK, Choudhury NR. Siddique T, et al. Among authors: choudhury nr. Membranes (Basel). 2021 Jul 23;11(8):557. doi: 10.3390/membranes11080557. Membranes (Basel). 2021. PMID: 34436320 Free PMC article. Review.
Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo.
Chapple CR, Cruz F, Cardozo L, Staskin D, Herschorn S, Choudhury N, Stoelzel M, Heesakkers J, Siddiqui E. Chapple CR, et al. Among authors: choudhury n. Eur Urol. 2020 Jan;77(1):119-128. doi: 10.1016/j.eururo.2019.09.024. Epub 2019 Oct 18. Eur Urol. 2020. PMID: 31635815 Free article. Clinical Trial.
siRNA-Conjugated Nanoparticles to Treat Ovarian Cancer.
Halbur C, Choudhury N, Chen M, Kim JH, Chung EJ. Halbur C, et al. Among authors: choudhury n. SLAS Technol. 2019 Apr;24(2):137-150. doi: 10.1177/2472630318816668. Epub 2019 Jan 7. SLAS Technol. 2019. PMID: 30616494 Review.
521 results